All Patients | LQ-Patients | ||||||
---|---|---|---|---|---|---|---|
total | No RT | Neoadjv. RCT | Adjv. RT | total | No RT | Neoadjv. RCT | |
N = | 182 | 75 (41%) | 89 (49%) | 13 (7%) | 70 | 31 (44%) | 39 (56%) |
Median Age at first diagnosis [years] | 58 | 59 | 59 | 54 | 57 | 56 | 60 |
Grading | |||||||
G1 | 36 (20%) | 36 (48%) | 4 (4%) | – | 18 (25%) | 18 (59%) | 4 (9%) |
G2 | 64 (35%) | 23 (30%) | 34 (38%) | 2 (18%) | 26 (37%) | 8 (27%) | 16 (42%) |
G3 | 78 (43%) | 17 (22%) | 51 (57%) | 9 (73%) | 25 (35%) | 4 (14%) | 19 (49%) |
Medium size of excision | |||||||
< 10 cm | 104 (57%) | 48 (64%) | 45 (51%) | 11 (82%) | 43 (61%) | 23 (73%) | 19 (50%) |
≥ 10 cm | 78 (43%) | 28 (37%) | 44 (49%) | 2 (18%) | 27 (39%) | 8 (27%) | 19 (50%) |
Localization | |||||||
Lower Extremity | 137 (75%) | 54 (72%) | 70 (79%) | 8 (62%) | 51 (73%) | 20 (65%) | 31 (80%) |
Upper Extremity | 45 (25%) | 21 (28%) | 19 (21%) | 5 (39%) | 19 (27%) | 11 (35%) | 8 (20%) |
5-year Survival rate | 149 (82%) | 68 (90%) | 68 (76%) | 10 (77%) | no calculation due to censored data | ||
10-year Survival rate | 129 (71%) | 62 (83%) | 61 (68%) | – | |||
Local recurrence | 28 (15%) | 19 (10%) | 7 (4%) | 2 (1%) | 6 (9%) | 5 (16%) | 1 (3%) |
Metastasis | 42 (23%) | 12 (7%) | 26 (14%) | 4 (2%) | 6 (9%) | 2 (7%) | 3 (8%) |